Novel Marker Of Colon Cancer Date: October 27, 2008 Source: World Journal of Gastroenterology Summary: The studies examined the gene profiles in non-invasive and invasive colon cancer using laser ...

Up to 16% of patients with submucosal invasive (T1) colorectal carcinoma are reported to have lymph node metastasis, whereas lymph node metastasis is reportedly absent in patients with mucosal ...

The expression profiles obtained by the cDNA array clearly indicate that colorectal adenomas and early invasive carcinomas have specific expression profiles.

The biopsy revealed well- to moderately differentiated invasive adenocarcinoma. CT abdomen and pelvis demonstrated a sigmoid annular lesion without definite evidence of distant metastatic disease.

In cancer care, accurate tools for predicting whether a tumor will spread (metastasize) can help patients receive the most appropriate treatments. But existing prediction methods don't always work ...

In contrast, there are also cases of submucosal invasive colorectal carcinoma that are not treated by additional surgical resection in which LN metastasis does occur. [14–22] Therefore, if we ...

Less-invasive ways to screen for colon cancer include a scope with LEDs and three cameras that give a nearly 360-degree view of the colon.

Rates of pancreatic adenocarcinoma increased significantly among younger individuals than older ones. Colorectal adenocarcinoma diagnoses also have increased among patients aged 15 to 34 years.

Colon cancer screening saves lives, and now there may be an effective non-invasive option for people who skip screening because they fear a colonoscopy. A new DNA stool test called Cologuard was ...

A doctoral student at the University of Texas at El Paso is digging deep with a new, less invasive way of undergoing a colonoscopy procedure.

Biopsy revealed invasive lobular carcinoma. Staging computed tomography scan demonstrated pulmonary nodules within the left upper and right lower lobes and focal thickening of the mid-transverse colon ...

The invasive mucinous adenocarcinoma subtype and other variants described in the IASLC/ATS/ERS classification were excluded from the statistical analyses to focus on these five subtypes.